Asian Pacific cooperative study of allogeneic bone marrow transplantation

Toru Masaoka, Akira Hiraoka, Shinichiro Okamoto, Yosihisa Kodera, Lu Xien Cao, Dao Pei Lu, Yao Chan Chen, Po Min Chen, Dong Jip Kim, Edmond Chiu, Raymond Liang, Alan Teh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The first cooperative study of the Asian Pacific bone marrow transplantation group included 75 patients with early leukemia who received human leukocyte antigen-matched sibling bone marrow transplants and were randomized into granulocyte colony-stimulating factor and control groups. The selected patients were registered from 10 centers in six countries and areas within Asia (Beijing, Taipei, Hong Kong, Japan, Korea, and Malaysia). The incidence of grades II-IV acute graft-vs.-host disease was 22.2%, and the 2-year survival rate was 62.7%. The period of protective isolation (27.1-66.7 days), period of hospitalization (38.6-130.5 days), and medical costs for 4 months (US $10,300-US $80,803) varied considerably. Good cooperation, i.e., low rate of protocol violation or rapid and precise presentation of case reports, was obtained.

Original languageEnglish
Pages (from-to)190-192
Number of pages3
JournalInternational Journal of Hematology
Volume70
Issue number3
Publication statusPublished - 1999

Fingerprint

Homologous Transplantation
Bone Marrow Transplantation
Transplants
Malaysia
Hong Kong
Granulocyte Colony-Stimulating Factor
Korea
HLA Antigens
Siblings
Japan
Leukemia
Hospitalization
Survival Rate
Bone Marrow
Costs and Cost Analysis
Control Groups
Incidence
Beijing

Keywords

  • Asian bone marrow transplantation
  • Bone marrow transplantation costs
  • Granulocyte colony-stimulating factor
  • Period of hospitalization

ASJC Scopus subject areas

  • Hematology

Cite this

Masaoka, T., Hiraoka, A., Okamoto, S., Kodera, Y., Cao, L. X., Lu, D. P., ... Teh, A. (1999). Asian Pacific cooperative study of allogeneic bone marrow transplantation. International Journal of Hematology, 70(3), 190-192.

Asian Pacific cooperative study of allogeneic bone marrow transplantation. / Masaoka, Toru; Hiraoka, Akira; Okamoto, Shinichiro; Kodera, Yosihisa; Cao, Lu Xien; Lu, Dao Pei; Chen, Yao Chan; Chen, Po Min; Kim, Dong Jip; Chiu, Edmond; Liang, Raymond; Teh, Alan.

In: International Journal of Hematology, Vol. 70, No. 3, 1999, p. 190-192.

Research output: Contribution to journalArticle

Masaoka, T, Hiraoka, A, Okamoto, S, Kodera, Y, Cao, LX, Lu, DP, Chen, YC, Chen, PM, Kim, DJ, Chiu, E, Liang, R & Teh, A 1999, 'Asian Pacific cooperative study of allogeneic bone marrow transplantation', International Journal of Hematology, vol. 70, no. 3, pp. 190-192.
Masaoka, Toru ; Hiraoka, Akira ; Okamoto, Shinichiro ; Kodera, Yosihisa ; Cao, Lu Xien ; Lu, Dao Pei ; Chen, Yao Chan ; Chen, Po Min ; Kim, Dong Jip ; Chiu, Edmond ; Liang, Raymond ; Teh, Alan. / Asian Pacific cooperative study of allogeneic bone marrow transplantation. In: International Journal of Hematology. 1999 ; Vol. 70, No. 3. pp. 190-192.
@article{676db6274a574ece9b2e655a06f13b5a,
title = "Asian Pacific cooperative study of allogeneic bone marrow transplantation",
abstract = "The first cooperative study of the Asian Pacific bone marrow transplantation group included 75 patients with early leukemia who received human leukocyte antigen-matched sibling bone marrow transplants and were randomized into granulocyte colony-stimulating factor and control groups. The selected patients were registered from 10 centers in six countries and areas within Asia (Beijing, Taipei, Hong Kong, Japan, Korea, and Malaysia). The incidence of grades II-IV acute graft-vs.-host disease was 22.2{\%}, and the 2-year survival rate was 62.7{\%}. The period of protective isolation (27.1-66.7 days), period of hospitalization (38.6-130.5 days), and medical costs for 4 months (US $10,300-US $80,803) varied considerably. Good cooperation, i.e., low rate of protocol violation or rapid and precise presentation of case reports, was obtained.",
keywords = "Asian bone marrow transplantation, Bone marrow transplantation costs, Granulocyte colony-stimulating factor, Period of hospitalization",
author = "Toru Masaoka and Akira Hiraoka and Shinichiro Okamoto and Yosihisa Kodera and Cao, {Lu Xien} and Lu, {Dao Pei} and Chen, {Yao Chan} and Chen, {Po Min} and Kim, {Dong Jip} and Edmond Chiu and Raymond Liang and Alan Teh",
year = "1999",
language = "English",
volume = "70",
pages = "190--192",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Asian Pacific cooperative study of allogeneic bone marrow transplantation

AU - Masaoka, Toru

AU - Hiraoka, Akira

AU - Okamoto, Shinichiro

AU - Kodera, Yosihisa

AU - Cao, Lu Xien

AU - Lu, Dao Pei

AU - Chen, Yao Chan

AU - Chen, Po Min

AU - Kim, Dong Jip

AU - Chiu, Edmond

AU - Liang, Raymond

AU - Teh, Alan

PY - 1999

Y1 - 1999

N2 - The first cooperative study of the Asian Pacific bone marrow transplantation group included 75 patients with early leukemia who received human leukocyte antigen-matched sibling bone marrow transplants and were randomized into granulocyte colony-stimulating factor and control groups. The selected patients were registered from 10 centers in six countries and areas within Asia (Beijing, Taipei, Hong Kong, Japan, Korea, and Malaysia). The incidence of grades II-IV acute graft-vs.-host disease was 22.2%, and the 2-year survival rate was 62.7%. The period of protective isolation (27.1-66.7 days), period of hospitalization (38.6-130.5 days), and medical costs for 4 months (US $10,300-US $80,803) varied considerably. Good cooperation, i.e., low rate of protocol violation or rapid and precise presentation of case reports, was obtained.

AB - The first cooperative study of the Asian Pacific bone marrow transplantation group included 75 patients with early leukemia who received human leukocyte antigen-matched sibling bone marrow transplants and were randomized into granulocyte colony-stimulating factor and control groups. The selected patients were registered from 10 centers in six countries and areas within Asia (Beijing, Taipei, Hong Kong, Japan, Korea, and Malaysia). The incidence of grades II-IV acute graft-vs.-host disease was 22.2%, and the 2-year survival rate was 62.7%. The period of protective isolation (27.1-66.7 days), period of hospitalization (38.6-130.5 days), and medical costs for 4 months (US $10,300-US $80,803) varied considerably. Good cooperation, i.e., low rate of protocol violation or rapid and precise presentation of case reports, was obtained.

KW - Asian bone marrow transplantation

KW - Bone marrow transplantation costs

KW - Granulocyte colony-stimulating factor

KW - Period of hospitalization

UR - http://www.scopus.com/inward/record.url?scp=0033210422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033210422&partnerID=8YFLogxK

M3 - Article

VL - 70

SP - 190

EP - 192

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -